Sunken cheeks aren't simply a function of age — they're the visible result of three parallel processes: bone resorption at the zygomatic arch, displacement of deep and superficial fat compartments, and loosening of the supporting ligaments. In my practice, patients in their mid-40s often arrive not wanting to be "filled" but wanting to understand what is actually happening. This article sorts the options — from hyaluronic acid to energy-based tightening — and says what each does in which phase. And what it doesn't.
Why cheeks sink and jowls form
Three things happen in parallel from around the mid-30s onwards. The cheekbone loses measurable substance — radiologically demonstrable. The deep fat compartments shift. And the ligaments that hold the midface up become longer. What appears in the mirror as "sunken" is, in cross-section, a cascade.
Jowls form precisely where this system gives way visibly: at the lateral lower jaw, where the cheek no longer carries the volume above and the jaw contour loses its clean line. Once you understand this, the question shifts: not "Which injection?" but "Which step first?"
At minimal med I begin first consultations on this topic with anatomy, not with product. Only when it's clear whether the problem sits above (cheek volume), below (jaw contour) or throughout (skin quality) does treatment selection make sense.
The three pillars: volume, structure, skin quality
Every meaningful treatment falls into one of these three pillars — and most concepts need more than one.
Volume. Tissue that is added or built up. Hyaluronic acid works immediately, biostimulators like Sculptra over weeks. The aim: lift the mid-cheek upward, rather than filling underneath.
Structure. The defining lines — jaw contour, chin, cheekbone angle. Firmer materials such as Radiesse, in combination with muscle modulation at the platysma and masseter (Jawline Contouring).
Skin quality. Elasticity, hydration, dermal density. Profhilo, skin boosters, polynucleotides, mesotherapy. Won't fill a sunken cheek — but ensures that what sits underneath doesn't show through.
Addressing only one pillar treats only a third of the problem.
The treatment spectrum at a glance
The overview below is ordered clinically, not alphabetically. Onset, duration and risk profile are experience values that vary individually — metabolism, location and placement depth shift every column.
| Treatment | Mechanism | Onset | Duration | Main zone | Risk profile | Indication |
|---|---|---|---|---|---|---|
| Volumising HA | Direct volume placement | immediate | 12–18 months | Cheek, chin, jawline | Swelling, bruising; rarely vascular | may support sunken contours |
| Mid-viscosity HA | Wrinkle filling | immediate | 9–12 months | Nasolabial, marionette | Bruising, Tyndall if too superficial | may soften deep folds |
| Sculptra (PLLA) | Type I/III collagen synthesis | 4–8 weeks | 18–24 months | Mid/lower face, broad area | Nodules with poor technique; delayed reactions possible | may support skin structure and gradual volume |
| Radiesse (CaHA) | Immediate volume + biostimulation | immediate + 3 mo. | 12–15 months | Jawline, deep cheek | Nodules; not reversible | may sharpen contours |
| Profhilo | Hydration + collagen stim. | 4–6 weeks | 6–9 months | Cheek, neck | Very low: brief papules | may support skin elasticity |
| Skin Booster | Deep hydration | 2–4 weeks | 4–6 months | Cheek, neck, décolleté | Papules 24–48 h | may support skin quality |
| Polynucleotides | Fibroblast activation | 4–8 weeks | 6–9 months | Periorbital, cheek | Very low | may support dermal density |
| Mesotherapy | Micronutrient depots | cumulative | 3–4 months | Broad area | Microbruising | may support glow |
| Mid/Lower Muscle Modulation | Nefertiti, masseter, DAO | 5–14 days | 3–4 months | Jawline, neck, mouth corners | Temporary asymmetry | may reduce downward muscle pull |
| Energy-based (HIFU/RF) | Deep heating, collagen contraction | 4–12 weeks | 9–12 months | Broad area | Swelling, rarely burns | may support skin tightening |
Anyone hoping to derive a favourite product from this table will fail. It's a map, not a recipe. Genuinely fitting recommendations only emerge when finding, expectation and timeframe are read together.
What works when: by life phase and finding
35–45: prevention and skin quality
In this phase, what carries skin quality is often enough. Profhilo twice a year, mesotherapy as a boost, occasional fine hyaluronic acid placements at nasolabial or tear trough. Early intervention means less work later. The skin remains the standard.
45–55: structural work begins
Volume becomes a question here. Sculptra for broad cheek structure, Radiesse for the jawline, hyaluronic acid for clearly defined deficits. A single Nefertiti session reduces downward muscle pull and relieves the jaw contour. Two to three coordinated appointments over six months is usually appropriate — not a single visit.
55+: concept rather than spot
Now it pays off to think across multiple pillars at once. Volume, contour and skin quality can no longer be treated independently. We developed the full-face concept precisely for this phase — staged planning rather than isolated sessions.
What spot treatment doesn't solve
Filling only the nasolabial fold treats the symptom. The cause often lies in the cheek volume above. Ignored, the fold looks overfilled three months later while the midface continues to drop — and the face overall sits heavier.
The same applies to jowls. Filling directly along the lower edge can briefly smooth the line. But if the cheek above doesn't carry, the sag returns the next season — only with more material in it. This is the most common reason patients feel "off" after several treatments without being able to say why.
A concept-based approach uses natural anatomy rather than working against it. When this makes sense and how it runs in practice is described on the concept page.
Risks and limits — honestly
Every minimally invasive treatment carries risk. Swelling and bruising are common and harmless. The Tyndall effect from superficially placed hyaluronic acid, nodules with biostimulators, vascular complications are rarer — but relevant. Recognised through training, experience and appropriate technique.
What no procedure delivers: closing skin laxity beyond a certain threshold. At some point, surgical lifting is the more honest tool. Saying that openly is part of every first consultation — even when it means referring a patient to plastic surgery.
Patience is also a limit. Sculptra works over weeks. Whoever lacks patience is better served with hyaluronic acid — visible faster, but shorter-lived. More on expectations and timing: biostimulators compared.
Frequently asked questions
Are jowls the same as sagging cheeks?
Jowls are the lateral sagging areas along the jawline that appear when cheek volume drops and the jaw contour loses its definition. Sagging cheeks is the broader term — jowls describe the phenomenon along the jawline specifically.
Which volume-loss treatment lasts longest?
Sculptra at 18–24 months and volumising hyaluronic acid placements at the cheek at 12–18 months are among the longer-lasting options. Duration varies by location, metabolism and depth of placement.
Can a single treatment eliminate jowls?
In most cases, no. Jowls arise from several parallel processes — volume loss above, skin laxity, downward muscle pull. A single injection rarely addresses all three. A staged combination usually makes more sense.
What is the difference between filler and biostimulator?
Fillers add volume immediately at the placement site. Biostimulators trigger the body's own collagen production — the result builds over weeks, but lasts longer and uses your own tissue rather than added material.
From what age does this make sense?
Volume loss is measurable from the mid-30s. Earlier intervention typically focuses on skin quality and light structural support. Later, multi-stage concepts become necessary. There is no "right" age — only the appropriate clinical finding.
What are the risks?
Common: swelling, bruising, brief tenderness. Rare but relevant: nodules with biostimulators, the Tyndall effect with superficially placed hyaluronic acid, vascular complications. These are recognised through training and managed with appropriate technique.